Developed a CRISPR-based platform for disease to enable the detection of any type of nucleic acid.
You can scroll over the chart's area to move in time and tap to see a specific date.
Highest Bid
$ 260.80
Lowest Offer
$ 188.50
Last Trade
$ 234.00
Live Orders
1,298
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Mammoth Biosciences is a biotechnology company based in Brisbane, California, that focuses on developing diagnostic tests and therapies using advanced CRISPR technology. Mammoth Biosciences aims to leverage its proprietary ultracompact CRISPR systems for various applications, including gene editing and decentralized precision diagnostics.
Mammoth Biosciences Funding
Sign up to gain insights into Mammoth Biosciences funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series D | Apr 22, 2024 | 107M | ||
| Series D | Aug 05, 2021 | 150M | ||
| Series C | May 19, 2020 | 49M | ||
| Series C | May 19, 2020 | 748K | ||
| Series B | Feb 24, 2020 | 37M | ||
| Series B | Feb 24, 2020 | 7M | ||
| Series A | Feb 25, 2019 | 5M | ||
| Series A | May 15, 2018 | 13M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Mammoth Biosciences Management Team
Investors
Verily Life Sciences
Redmile Group
Decheng Capital
Greenspring Associates
Foresite Capital
Senator Investment Group
8VC
Plum Alley Co.
Sixth Street Partners
Mayfield Fund
Pacific 8 Ventures
aMoon Fund
NFX
Mammoth Biosciences Valuations & Financials
View real-time NPM data on Mammoth Biosciences stock including daily Mammoth Biosciences stock price estimates, valuation history, and historical share price information. Access Mammoth Biosciences financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Mammoth Biosciences pricing across six independent market signals. Looking for private company due diligence data sources on Mammoth Biosciences? Get in touch to learn more.
Similar Companies
like Mammoth Biosciences
Curology
Healthcare & Life Sciences
Offers personalized prescription skin care medications delivered directly to you.
Cedar
Healthcare & Life Sciences
The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.
Resilience
Healthcare & Life Sciences
Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.
Cerebral
Healthcare & Life Sciences
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Devoted Health
Healthcare & Life Sciences
Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.
Ro
Healthcare & Life Sciences
Healthcare technology for a patient-centric healthcare system.
Honor
Healthcare & Life Sciences
Connects people seeking non-medical, in-home personal care for seniors with independent care service providers.
Owkin
Healthcare & Life Sciences
Biotechnology company using AI to personalize treatment.
FAQ
We have answers
Mammoth Biosciences stock does not trade on public stock exchanges. Mammoth Biosciences stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Mammoth Biosciences stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Mammoth Biosciences Stock does not trade on public stock exchanges. In order to sell Mammoth Biosciences shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Nasdaq Private Market estimates that Mammoth Biosciences price per share was $8.41 as of June 12, 2026. This Mammoth Biosciences share value estimate (known as the NPM price) is based on market activity, publicly-sourced valuation data, and other proprietary information. With NPM Data and Intelligence premium for investors, you can get visibility into the Mammoth Biosciences share price today and the factors driving Mammoth Biosciences valuation estimates. Learn more about premium data here.
Read more about private company stock prices: Understanding the Bid-Ask Spread: How Buyers and Sellers Match on Price
There is no ticker symbol for Mammoth Biosciences stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Mammoth Biosciences stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Mammoth Biosciences stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Mammoth Biosciences is a private company and has not had an IPO. There is currently no Mammoth Biosciences IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Mammoth Biosciences IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
